Remove 2006 Remove Consumption Remove History Remove Safety
article thumbnail

CBD Ban: Brits Take Up Fight And Send Lawyers To Brussels

Cannabis Law Report

London law firm Mackrell Turner Garrett, together with a leading food and trading standards barrister, were instructed by the Cannabis Trades Association UK (CTA) to make representations to the European Food Safety Authority (EFSA).

CBD 87
article thumbnail

Italy: MINISTRY OF HEALTH DECREE – Definition of maximum levels of tetrahydrocannabinol (THC) in food

Cannabis Law Report

the European Food Safety Authority and establishes procedures in the. food safety; Having regard to Regulation (EC) no. animal intended for human consumption; Having regard to Regulation (EC) no. 1881/2006 of the Commission dated 19. 1881/2006 of the Commission dated 19. 178/2002 of the European Parliament and of.

Food 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cannabis & THC: Understanding the Effects & Liability

Cannabis Law Report

THC metabolism (adapted from Musshoff and Madea, 2006). Durations for urine detection primarily vary with dose consumed and use history (i.e., single use vs. chronic/daily consumption), but also can vary with other factors such as body mass, weight loss, and exercise. use history, dose, elapsed time since use, etc.)

THC 52
article thumbnail

Is Your Cannabis Billboard DCC Compliant in California?

Cannabis Law Report

In 2006 Tiffiny earned her J.D. in history. DCC regulations were established to ensure product safety and public protection. As the cannabis industry continues to expand and legalization on the federal level is imminent, regulations are likely to become even more restrictive in the interest of public safety.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It also has an extensive and diverse history of medicinal use. 2018 ; Frankhauser 2008 ).